Iveric bio Inc. | OPHT - Current Liabilities


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Iveric bio Inc.

Iveric bio Inc. reported $39.37M in Current Liabilities for its fiscal quarter ending in March of 2023.


Current Liabilities Change
Alimera Sciences ALIM:US USD 14.17M 25.56M
Insmed INSM:US USD 187.98M 2.26M
Iveric bio Inc. OPHT:US USD 39.37M 3.79M
Nektar Therapeutics NKTR:US USD 59.88M 8.32M
Novartis NOVN:VX USD 30.55B 1.89B
Regeneron Pharmaceuticals REGN:US USD 3.1B 41.2M
Roche Holding ROG:VX 27.24B 170M